A Review on the Effect and Treatment of Respiratory Disease Caused by Syncytial Virus

Abstract

The treatment and management of respiratory syncytial virus (RSV) infections in children are discussed in this review of the state of the science. Regrettably, there is no effective treatment at this time. Purpose of this review to know better diagnosis & treatments procedure of Respiratory syncytial virus. Methods for assembly and analyzing data, collected number of many related review paper from 2000 to 2022 review paper by using many search engines like PubMed, Research Gate, Google scholar and Medline etc. Corticosteroids and bronchodilators have not yet been proven to be effective. Ribavirin use is restricted to a very small number of high risk T-cell immunodeficient patients who have been thoroughly documented. Investigations on the effectiveness of vitamin A, interferon, and antibiotics produced underwhelming findings. Potential vaccines have been developed through vaccination research, including the recombinant vaccine BBG2Na, a subunit vaccine PFP-2, and vaccinations that are temperature- and cold-sensitive. The effects of bronchodilators (albuterol, metaproterenol, or ipratropium) were examined in a total of 24 published investigations. RSV infection manifestations have also been treated with epinephrine, which can be administered orally or intravenously (racemic epinephrine). Clinical practice recommendations are undeniably very efficient, and once implemented, they can be maintained and the gains made can continue. There are at least three different research lab methods for RSV identification. Immunofluorescence and enzyme immunoassay are two methods used to check for RSV antigens in nasal washes.